ACHE and Alzheimer disease: Huperzine A, which reversibly and selectively inhibits acetylcholinesterase and is utilized for AD treatment, has been reported to have a neuroprotecting impact by activating Wnt/β-catenin signaling in AD (Wang et al., 2011).